Astrazeneca informs EU of vaccine delivery issues

Discontent in the EU is growing

Astrazeneca now sees fewer vaccine deliveries post-approval.
It’s not going to be a good look for the EU when the US, UK and a few other countries reach heard immunity well before them. It’s not like the EU has a lot of positive political capital to start with.
The difference is going to look good for the UK.
In the bigger picture, the growth outlook in the EU is dismal and that’s the longer-term risk.